top of page
Ablatotech Clinical Trials

Join the Groundbreaking Clinical Trials for Tarysol – A Revolutionary Treatment for Thrombosis

Are you or a loved one living with blood clot-related health conditions? Ablatotech is conducting clinical trials for Tarysol, a natural, cutting-edge drug designed to rapidly and safely dissolve blood clots within hours.

​

We are seeking volunteers to participate in this pivotal research that has the potential to transform the treatment of thrombosis and improve countless lives. Your participation could help advance medical science and offer new hope for those affected by blood clots.

 

Eligibility Requirements:

 

We are looking for individuals who:

  • Have been diagnosed with thrombosis or related blood clot conditions.

  • Meet specific health criteria as determined during the screening process.

  • Are willing to attend scheduled appointments and adhere to study protocols.

 

Why Participate?

  • Contribute to groundbreaking medical innovation.

  • Access a promising investigational treatment under expert medical supervision.

  • Receive medical care and potential compensation for your time and travel.

 

Your journey as a participant in this study will help shape the future of thrombosis treatment, bringing us closer to safer, more effective solutions for blood clot-related conditions.

 

Contact Us to Learn More

 

If you are interested in participating or would like to know more about the Tarysol clinical trials, please contact:

 

Act now to take part in this life-changing research. Together, we can redefine the future of thrombosis treatment!

Submitted! Thanks for your interest in Tarysol clinical trials.

    © 2022 Ablatotech

    bottom of page